Defining Spectral Quality in Mass Spectrometry-Based Proteomics: A Retrospective Review.

Area of Science:

• Proteomics
• Bioinformatics
• Preventive Medicine

Background:

• Mass spectrometry-based proteomics is crucial for personalized medicine.
• Technological advances increase spectral data, complicating peptide identification and false discovery rate control.
• Current methods often rely on post-processing database searches, which can be computationally intensive.

Purpose of the Study:

• To provide a comprehensive review of spectral quality assessment in proteomics.
• To examine existing tools and principles for classifying spectra.
• To highlight the potential of spectral quality assessment for improving peptide identification.

Main Methods:

• Review of existing literature and tools for spectral quality assessment.
• Discussion of key considerations including spectral quality definition, normalization, and training data.
• Analysis of the impact of preprocessing spectra versus post-processing rescoring.

Main Results:

• Spectral quality assessment offers a promising preprocessing alternative to manage false discoveries.
• This method can enhance the accuracy of peptide identification by filtering noisy spectra.
• The review covers various aspects from defining quality to future research directions.

Conclusions:

• Spectral quality assessment is a valuable technique for improving the reliability of mass spectrometry-based proteomics.
• By filtering low-quality spectra, this method can reduce false discovery rates and enhance peptide identification accuracy.
• Further research into spectral quality assessment holds significant potential for the proteomics community and personalized medicine.